Semaglutide has completely changed obesity medicine and one of the ways it has done this is through craving reduction. My patients often experience fewer food and sugar cravings while on semaglutide. With fewer cravings comes a decrease in nighttime snacking, stress-eating, and better food choices overall. Interestingly enough sugar is not the only craving reduction my patients have been noting. Many patients are also describing a decreased desire to drink alcohol with semaglutide. A lot of patients that previously drank several drinks nightly are finding that alcohol just doesn’t sound good to them anymore. I have seen this lead to a significant reduction in alcohol consumption as well as weight loss with the elimination of these empty calories.

Reduction in alcohol cravings with semaglutide is now being recognized by healthcare providers nationwide. Using semaglutide to treat alcohol use disorder is something that we will likely see being studied in depth these next couple of years. Right now, more research is needed before this medication gets the FDA label to treat alcohol use disorders.

Kristine is the founder of WeightMed PLLC, Washington’s Premier Obesity Medicine Clinic. WeightMed PLLC prescribes semaglutide and tirzepatide in the Seattle, Puget Sound area, Vancouver, Spokane Valley, and all of Washington State. WeightMed PLLC sees patients virtually usually our HIPPA-compliant platform and medications are shipped directly from our Seattle based pharmacy partner to your door.